-
Gocovri Shown to Improve Motor Symptoms in Parkinson’s Patients
Treatment with Gocovri (amantadine) reduced Parkinson’s dyskinesia — involuntary, jerky movements — and so-called “off” episodes, leading to longer periods of controlling motor symptoms, Phase 3 clinical trial results show.
Click here to read a summary of the trial’s results: Gocovri Reduces Transitions Between Dyskinesia and ‘Off’ Episodes, Trial Results Show
Have you heard of this drug? What do you think about this news?
Sorry, there were no replies found.
Log in to reply.